833 related articles for article (PubMed ID: 12917166)
21. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
24. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
Van de Moere A; Sandhu SS; Kak R; Mitchell KW; Talks SJ
Ophthalmology; 2005 Nov; 112(11):1896-903. PubMed ID: 16214216
[TBL] [Abstract][Full Text] [Related]
25. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
26. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
Kaiser PK; ; Boyer DS; Garcia R; Hao Y; Hughes MS; Jabbour NM; Kaiser PK; Mieler W; Slakter JS; Samuel M; Tolentino MJ; Roth D; Sheidow T; Strong HA
Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834
[TBL] [Abstract][Full Text] [Related]
27. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
28. Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
Schadlu R; Kymes SM; Apte RS
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1667-72. PubMed ID: 17583819
[TBL] [Abstract][Full Text] [Related]
29. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D
Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538
[TBL] [Abstract][Full Text] [Related]
30. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study.
Chan A; Blumenkranz MS; Wu KH; Wang G; Berker N; Parast LM; Sanislo SR
Ophthalmic Surg Lasers Imaging; 2009; 40(6):561-9. PubMed ID: 19928721
[TBL] [Abstract][Full Text] [Related]
32. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
Iriyama A; Obata R; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556
[TBL] [Abstract][Full Text] [Related]
33. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.
Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F
Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791
[TBL] [Abstract][Full Text] [Related]
34. Combination photodynamic therapy and intravitreal ranibizumab in neovascular age-related macular degeneration in a North Indian population: a pilot study.
Kumar A; Gopalakrishnan K; Sinha S
Retina; 2008 Oct; 28(9):1296-301. PubMed ID: 18667951
[TBL] [Abstract][Full Text] [Related]
35. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
37. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
Marticorena J; Gomez-Ulla F; Fernandez M; Pazos B; Rodriguez-Cid MJ; Sanchez-Salorio M
Am J Ophthalmol; 2006 Aug; 142(2):335-7. PubMed ID: 16876524
[TBL] [Abstract][Full Text] [Related]
38. The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Feuer WJ
Ophthalmic Surg Lasers Imaging; 2008; 39(1):12-6. PubMed ID: 18254345
[TBL] [Abstract][Full Text] [Related]
39. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
Liggett PE; Colina J; Chaudhry NA; Tom D; Haffner G
Am J Ophthalmol; 2006 Dec; 142(6):1072-4. PubMed ID: 17157599
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
Ho TC
Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
